John Schwieters - Danaher Independent Director
| DHR Stock | USD 253.11 17.03 7.21% |
Director
Mr. John T. Schwieters is Independent Director of the Company since 2003.
| Age | 81 |
| Tenure | 21 years |
| Address | 2200 Pennsylvania Avenue, North West, Washington, DC, United States, 20037-1701 |
| Phone | 202 828 0850 |
| Web | https://www.danaher.com |
Danaher Management Efficiency
The company has Return on Asset of 0.0398 % which means that on every $100 spent on assets, it made $0.0398 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0815 %, implying that it generated $0.0815 on every 100 dollars invested. Danaher's management efficiency ratios could be used to measure how well Danaher manages its routine affairs as well as how well it operates its assets and liabilities. As of 04/24/2024, Return On Equity is likely to grow to 0.15, while Return On Tangible Assets are likely to drop 0.14. At this time, Danaher's Debt To Assets are relatively stable compared to the past year. As of 04/24/2024, Fixed Asset Turnover is likely to grow to 5.76, while Return On Tangible Assets are likely to drop 0.14.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Ian Sacks | HealthEquity | 47 | |
| Martin Harris | HealthStream | 61 | |
| Evelyn Dilsaver | HealthEquity | 62 | |
| Brita Eilertsen | National Research Corp | 53 | |
| Deborah Tate | HealthStream | 61 | |
| Martiny Harris | HealthStream | 59 | |
| Jeffrey McLaren | HealthStream | 51 | |
| P Shastri | National Research Corp | 65 | |
| JoAnn Martin | National Research Corp | 63 | |
| Adrian Dillon | HealthEquity | 63 | |
| Barbara Mowry | National Research Corp | 70 | |
| Debra McCowan | HealthEquity | 46 | |
| Savita Acharya | National Research Corp | 41 | |
| Donald Berwick | National Research Corp | 71 | |
| Dale Polley | HealthStream | 67 | |
| Manu Rana | HealthEquity | 45 | |
| Frank Medici | HealthEquity | 53 | |
| Kjersti Kanne | National Research Corp | N/A | |
| William Stead | HealthStream | 69 | |
| Frank Gordon | HealthStream | 55 | |
| Michael Shmerling | HealthStream | 62 | |
Management Performance
| Return On Equity | 0.0815 | ||||
| Return On Asset | 0.0398 |
Danaher Leadership Team
Elected by the shareholders, the Danaher's board of directors comprises two types of representatives: Danaher inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Danaher. The board's role is to monitor Danaher's management team and ensure that shareholders' interests are well served. Danaher's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Danaher's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Ditkoff, Senior Vice President - Finance and Tax | ||
| Rainer Blair, President, Chief Executive Officer, Director | ||
| Angela Lalor, Senior Vice President - Human Resources | ||
| James Lico, Executive VP | ||
| Pardis Sabeti, Independent Director | ||
| A Sanders, Independent Director | ||
| William Daniel, Executive Vice President | ||
| Robert Hugin, Director | ||
| William King, Senior Vice President - Strategic Development | ||
| Matthew McGrew, Chief Financial Officer, Executive Vice President | ||
| Thomas Joyce, CEO and President Director and Member of Fin. Committee | ||
| Mitchell Rales, Chairman of the Executive Committee, Director | ||
| JoseCarlos GutierrezRamos, Senior Vice President Chief Scientific Officer | ||
| John Schwieters, Independent Director | ||
| Linda Filler, Lead Independent Director | ||
| Teri ListStoll, Independent Director | ||
| Daniel Raskas, Senior Vice President - Corporate Development | ||
| Daniel Comas, Executive Vice President | ||
| Elias Zerhouni, Independent Director | ||
| Brian Ellis, Senior Vice President, Chief Compliance Officer, General Counsel | ||
| Daniel JD, Senior Development | ||
| Raymond Stevens, Independent Director | ||
| Matthew Gugino, Vice President - Investor Relations | ||
| Jessica Mega, Independent Director | ||
| Steven Rales, Chairman of the Board | ||
| John Bedford, Vice Relations | ||
| Alan Spoon, Independent Director | ||
| Robert Lutz, Senior Vice President Chief Accounting Officer | ||
| Walter Lohr, Independent Director | ||
| Donald Ehrlich, Lead Independent Director | ||
| Christopher Bouda, Chief Accounting Officer, Vice President | ||
| Georgeann Couchara, Senior Vice President - Human Resources | ||
| Joakim Weidemanis, Executive Vice President | ||
| Jennifer Honeycutt, Executive Vice President |
Danaher Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Danaher a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0815 | ||||
| Return On Asset | 0.0398 | ||||
| Profit Margin | 0.20 % | ||||
| Operating Margin | 0.21 % | ||||
| Current Valuation | 188.3 B | ||||
| Shares Outstanding | 740.54 M | ||||
| Shares Owned By Insiders | 10.75 % | ||||
| Shares Owned By Institutions | 81.63 % | ||||
| Number Of Shares Shorted | 6.35 M | ||||
| Price To Earning | 29.97 X |
Pair Trading with Danaher
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Danaher position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Danaher will appreciate offsetting losses from the drop in the long position's value.Moving together with Danaher Stock
| 0.72 | FONR | Fonar | PairCorr |
Moving against Danaher Stock
| 0.42 | IRIX | IRIDEX Financial Report 9th of May 2024 | PairCorr |
The ability to find closely correlated positions to Danaher could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Danaher when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Danaher - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Danaher to buy it.
The correlation of Danaher is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Danaher moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Danaher moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Danaher can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Danaher. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. To learn how to invest in Danaher Stock, please use our How to Invest in Danaher guide.Note that the Danaher information on this page should be used as a complementary analysis to other Danaher's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Danaher Stock analysis
When running Danaher's price analysis, check to measure Danaher's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Danaher is operating at the current time. Most of Danaher's value examination focuses on studying past and present price action to predict the probability of Danaher's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Danaher's price. Additionally, you may evaluate how the addition of Danaher to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is Danaher's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Danaher. If investors know Danaher will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Danaher listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.51) | Dividend Share 1.05 | Earnings Share 5.64 | Revenue Per Share 32.437 | Quarterly Revenue Growth (0.23) |
The market value of Danaher is measured differently than its book value, which is the value of Danaher that is recorded on the company's balance sheet. Investors also form their own opinion of Danaher's value that differs from its market value or its book value, called intrinsic value, which is Danaher's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Danaher's market value can be influenced by many factors that don't directly affect Danaher's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Danaher's value and its price as these two are different measures arrived at by different means. Investors typically determine if Danaher is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Danaher's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.